Feb 02, 2021 / 01:00PM GMT
Operator
Good morning. My name is Melissa, and I will serve as your conference call operator. (Operator Instructions) As a reminder, this conference is being recorded.
Joining me on the call today will be Dr. Pete Salzmann, Chief Executive Officer of Immunovant.
Before we begin, I would like to remind everyone that today's conference call will include certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, for example, statements regarding potential efficacy and safety of Immunovant's product candidates; and Immunovant's expectations regarding the timing, design and results of its clinical trials, including the timing of future readouts and data readouts and the announcement of future indications. These forward-looking statements are not guarantees of future performance; and are subject to risks and uncertainties, assumptions known or unknown which could cause actual results to vary materially from those indicated or anticipated. For more information, investors are encouraged to review Immunovant's
Immunovant, Inc. - Special Call Transcript
Feb 02, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers